|
|
||||||||||||||||
|
|
|
|
|
|||||||||||||
|
|
Centers for Disease Control and Prevention Division of Cancer Prevention and Control 4770 Buford Hwy, NE MS K-64 Atlanta, GA 30341-3717 Call: 1 (800) CDC-INFO TTY: 1 (888) 232-6348 FAX: (770) 488-4760 E-mail: cdcinfo@cdc.gov |
|
|
|
Clinical Document Architecture (CDA) Pilot ProjectFor more than 10 years, the cancer registry community, with the North American Association of Central Cancer Registries (NAACCR), has provided detailed information for exchanging data from one entity to another. NAACCR defined the current method for transmitting a cancer abstract or a cancer public health report from one institution to another in Volume II, Data Standards and Data Dictionary.* This fixed-width, column-delimited structure has worked well over the years. However, given the limitations of the column-delimited format (such as adding new data items, transmitting text fields that are longer than the allowable values, and changing the character length of an existing data item) and NAACCR's priority to use national health information technology (IT) standards, NAACCR initiated a project to explore alternative message formats that will be consistent with those national health IT formats. After core criteria were applied to a variety of potential formats, the decision was made that the most appropriate format was HL7* Clinical Document Architecture (CDA). To explore the appropriateness of CDA for transmission of the cancer abstract more fully, NAACCR conducted a pilot test transmission of the cancer abstract from a hospital cancer registry to a central cancer registry using the CDA format. Working in collaboration with NAACCR, CDC's NPCR provided funding for technical assistance in the form of materials, tools, and guidance for this pilot test. The work scope for this project includes:
Project Implementation SpecificationsThis project plan anticipates a period of initial implementation before the EDITS software validation for native CDA is available. It will include developing utilities to do limited validation checking on CDA at the point of origin. The validation does not support the full suite of rules embodied in EDITS, but should be sufficient to ensure that the CDA instance will convert successfully to flat file format for submission, and will check for basic CDA and NAACCR conformance. Because of the anticipated length of time for the cancer registry community to transition from the flat file format to a CDA format, this project also will develop the bi-directional transformation tools to down-translate CDA to the NAACCR fixed-width, column-delimited or flat file format, and to up-translate the NAACCR flat file format to CDA. Flat files will be 100% compatible with CDA, while CDA will be constrained, initially, for conformance with flat file submission. When registry submission is not a limiting factor, native CDA submissions may be incompatible with a down translation, but flat file submissions will continue to be translatable to CDA. Thus, installations can continue to use the NAACCR flat file format submission without losing semantics while those that convert to CDA can begin to take advantage of the richer format. Project VocabularyThe initial CDA IG will use the NAACCR code sets and vocabularies as used in NAACCR flat file reporting today. In the future, an advantage of CDA will be adopting controlled terminology compatible with general clinical reporting applications and decision support such as SNOMED CT. Adopting general industry terminology could promote harmonization of the NAACCR data item codes with those used by national standard setters in the electronic health records. The design of the initial CDA IG, while not specifying the common terminologies, will anticipate a future IG that is compatible with:
Compatibility with these design patterns and vocabularies may support reuse and integration of cancer registry data for clinical trials, patient safety through drug-drug interaction checking against the medical record, and quality enhancement of registry data for public health purposes. *Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.
Page last reviewed: February 19, 2009
Page last updated: February 19, 2009 Content source: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion |
|
|
|
|
||||||||||||
|